RSCM
PFE icon

Rail-Splitter Capital Management’s Pfizer PFE Stock Holding History

Rail-Splitter Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-240,133
Closed -$7.92M – 44
2015
Q1 		$7.92M Buy
+240,133
New +$7.63M 2.42% 22

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Rail-Splitter Capital Management's PFE Position: Q2 2015 in Review

Rail-Splitter Capital Management sold out of Pfizer (PFE) in Q2 2015, closing a stake of 240,133 shares — an estimated $7.92M sold.

Rail-Splitter Capital Management first reported a position in PFE in Q1 2015 and held it in 1 quarter. The position peaked at $7.92M in Q1 2015. 1,886 funds tracked by Wall St. Rank hold PFE as of Q2 2015.

  • Rail-Splitter Capital Management reported no remaining Pfizer position as of Q2 2015 after selling out during the quarter.
  • Rail-Splitter Capital Management sold 240,133 Pfizer shares in Q2 2015, an estimated $7.92M.
  • Rail-Splitter Capital Management first reported a position in Pfizer in Q1 2015 and held it in 1 quarter.
  • Rail-Splitter Capital Management's Pfizer position peaked at $7.92M in Q1 2015.
  • 1,886 funds tracked by Wall St. Rank held Pfizer as of Q2 2015.

Based on Rail-Splitter Capital Management's 13F filing for Q2 2015, filed 31 Jul 2015.